( Alberta Health Services ) Fabry disease, a rare inherited enzyme deficiency, can shorten the lifespan of people who have it by as much as 40 years. Now, Canadian researchers have launched the first gene therapy clinical trial in the world for Fabry disease, which they hope will one day provide a cure.